RADIOHYBRID
LIVE

Serial Number

97695250

Owner

Technische Universität München

Attorney

Andrew D. Bochner

Filing Date

Nov 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RADIOHYBRID Trademark

Serial Number: 97695250 • Registration: 7772317

RADIOHYBRID is a trademark filed by Technische Universität München on November 29, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Technische Universität München

Arcisstraße 21
Munich 80333 , DE

Entity Type: 03

Trademark Details

Filing Date

November 29, 2022

Registration Date

April 22, 2025

Goods & Services

Medical, pharmaceutical and veterinary preparations for diagnosis, monitoring and treatment of cancer; sanitary preparations for medical use; diagnostic preparations for medical purposes; medical preparations in the nature of biometallic compounds for consumption or injection for use in medical imaging; contrast agents for use in medical imaging; amino acids for medical purposes; radioactive substances for medical purposes; reagents for medical use; Positron Emission Tomography (PET) tracer chemicals for medical use; Positron Emission Tomography (PET) tracer chemicals prepared for ingestion or injection into humans and animals for medical purposes; diagnostic chemicals for medical purposes; Therapeutic pharmaceutical for the treatment of cancer; reagents for medical purposes; diagnostic scanning agents for medical use; pharmaceutical preparations, namely, radiotherapeutic preparations and radio diagnostic preparations; Diagnostic medical preparations for use in molecular imaging; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; diagnostic radiopharmaceutical preparations; radiopharmaceutical products, namely, radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy; Pharmaceutical preparations, namely, alpha- and beta-emitting radionuclides for use in radionuclide therapy; synthetic amino acids for medical purposes, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy; reagents for medical use, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy

Chemicals for use in scientific research, other than for medical or veterinary purposes; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracer chemicals for scientific and laboratory use; radioactive elements for scientific purposes; diagnostic scanning agents for in-vivo use other than medical purposes; chemicals for use in molecular imaging for scientific or research use

Medical clinic services; Positron Emission Tomography (PET) imaging services; medical imaging services; medical analysis for the diagnosis and treatment of persons; medical consultations

Scientific and technological services, namely, research and design in the field of industrial analysis; industrial analysis and research services in the field of radiopharmaceuticals; design and development of computer hardware and software; product design and development in the field of Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in the field of disease diagnosis and treatment; scientific and medical research in the field of molecular imaging; development of molecular imaging products; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific research consulting in the field of medical imaging; Medical laboratory services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 22, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Apr 22, 2025 R.SR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 30, 2025 ERRR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 27, 2025 CNTA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 24, 2025 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 23, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 1, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 1, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 1, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2024 CRFA
ASSIGNED TO LIE
May 6, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 24, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 24, 2023 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2022 NWOS
NEW APPLICATION ENTERED
Dec 2, 2022 NWAP